SMAD7 and multiple sclerosis: Similarly, Abarca-Zabalia et al. [1] confirmed that Smad7 expression was decreased in the peripheral blood CD4+ T lymphocytes of patients with remittent recurrent multiple sclerosis during both acute relapses and in remission phases.